Business · Companies · 3 hrs ago
Biomemory launches synthetic-DNA service for long-term data storage
Biomemory has opened early access to DNA Shield, a service for organizations that want to preserve important digital information.
The company is based in Paris and has a Boston research and production hub after acquiring Catalog Technologies in March 2026.
The service encodes selected, encrypted data in synthetic DNA, which is kept offline and without power.
It is intended for items such as cryptographic keys, industrial secrets and regulated records that organizations need to keep intact for years.
Offline storage creates a separate layer away from network attacks, but DNA Shield is designed to complement existing security tools, not replace them.
Pilot access is expected to run through mid-2027, with a full service to follow; Biomemory says it plans to expand the broader Molecular IT platform.
Biomemory launched DNA Shield, a managed service that stores selected critical data in synthetic DNA offline.
The company says the service is intended to protect data from cyberattacks and other emerging risks, including advances in artificial intelligence and quantum computing.
DNA Shield’s Early Access Program is open to organizations, while TechRadar reports that pilot slots run from October 15, 2026, through mid-2027.
A full service is expected after the pilot period, according to TechRadar.
The service is the first product on Biomemory’s planned Molecular IT roadmap.
- Who
- Biomemory, a commercial DNA data storage company.
- What
- It launched DNA Shield, a managed offline service that encodes selected data in synthetic DNA.
- When
- Announced on October 15, 2026. TechRadar says pilot slots run through mid-2027.
- Where
- Biomemory is headquartered in Paris and has a production and research hub in Boston.
- Why
- To give organizations an offline layer for critical data that must remain trustworthy and recoverable over time.
This story does not have two clearly opposing sides.
Biomemory acquired the assets of Catalog Technologies, a Boston-based DNA data storage pioneer.
Biomemory named Laurent Guengant chief executive officer.
Biomemory announced DNA Shield and opened its Early Access Program.
TechRadar reports that DNA Shield pilot slots are available during this period.
- Service
- DNA Shield
- Storage medium
- Synthetic DNA
- Early access
- Program opened to organizations on October 15, 2026
- Pilot period
- October 15, 2026 through mid-2027, according to TechRadar
- Subscription price
- Starts at €10,000 per month, according to TechRadar
2 sources
What people are saying
DNA Shield is the moment Biomemory moves from proving a science to delivering a commercial product
Organizations need a way to hold their most critical digital assets, cryptographic keys, core intellectual property, regulated records, and long-term institutional memory, somewhere no single vendor, cloud, or system can reach, and to prove it still works over time.
DNA Shield is built on the same molecular platform we have spent years industrializing, but it is the first time we are asking a customer to rely on it operationally rather than as a research demonstration.